ArticleJournal of bone oncology2020

The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair.

Liang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.